These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 20525969)
1. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Graham DY; Fischbach L Gut; 2010 Aug; 59(8):1143-53. PubMed ID: 20525969 [TBL] [Abstract][Full Text] [Related]
2. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Gisbert JP; Calvet X Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241 [TBL] [Abstract][Full Text] [Related]
3. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366 [TBL] [Abstract][Full Text] [Related]
4. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002]. Buzás GM; Józan J Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Gisbert JP; Pajares JM Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345 [TBL] [Abstract][Full Text] [Related]
8. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Fischbach L; Evans EL Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938 [TBL] [Abstract][Full Text] [Related]
13. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Helicobacter pylori. Wolle K; Malfertheiner P Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279 [TBL] [Abstract][Full Text] [Related]
15. [First line therapy for Helicobacter pylori eradication in France]. Dupas JL Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298 [TBL] [Abstract][Full Text] [Related]
17. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]